Skip to main content
# Title Department Research Member Research Year
121 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Clinical Pathology Dr. Mohamed Galal Mostafa ELnaggar 2021
122 Increase in polymorphonuclear myeloid‑derived suppressor cells and regulatory T‑cells in children with B‑cell acute lymphoblastic leukemia Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2021
123 Laparoscopic versus Open Complete Mesocolic Excision for Right Colon Cancer Department of Pathology Dr. Marwa Tammam Ameen Hammam 2021
124 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Dr. Ali Zedan Tohamy mohammed 2021
125 The role of quantitative computed tomography perfusion in the assessment of colorectal thickening Department of Radiology Marwa Ali Mohammed Abdel fattah 2021
126 Association of robust radiomic features from staging18F-FDG PET/CT in lung cancer with EGFR over expression and overall survival Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2021
127 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
128 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Dr. Murad Aly Jabir Ahmed 2021
129 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Badawy, Mohammed Ahmed Mohammed 2021
130 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2021